Pulmonary Vascular Disease and Cardiopulmonary Exercise Testing - Sorbonne Université
Journal Articles Frontiers in Physiology Year : 2020

Pulmonary Vascular Disease and Cardiopulmonary Exercise Testing

Abstract

Cardiopulmonary exercise testing (CPET) is of great interest and utility for clinicians dealing Pulmonary Hypertension (PH) in several ways, including: helping with differential diagnosis, evaluating exercise intolerance and its underpinning mechanisms, accurately assessing exertional dyspnea and unmasking its underlying often non-straightforward mechanisms, generating prognostic indicators. Pathophysiologic anomalies in PH can range from reduced cardiac output and aerobic capacity, to inefficient ventilation, dyspnea, dynamic hyperinflation, and locomotor muscle dysfunction. CPET can magnify the PH-related pathophysiologic anomalies and has a major role in the management of PH patients.
Fichier principal
Vignette du fichier
fphys-11-00964.pdf (1.76 Mo) Télécharger le fichier
Origin Publication funded by an institution
Loading...

Dates and versions

hal-02934840 , version 1 (09-09-2020)

Identifiers

Cite

Pierantonio Laveneziana, Jason Weatherald. Pulmonary Vascular Disease and Cardiopulmonary Exercise Testing. Frontiers in Physiology, 2020, 11, pp.964. ⟨10.3389/fphys.2020.00964⟩. ⟨hal-02934840⟩
25 View
76 Download

Altmetric

Share

More